Arndt Vogel, Head of the Center for Personalized Medicine, MHH at Medical University of Hanover, shared a post on X about a paper he co-authored with colleagues published in JHEP Reports:
“Off the press!
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study
RWD, 1500 pts, 18 centers
Striking differences in GA detection rate
We provide predictive & prognostic impact of medicines
NGS is key in BTC.”
Title: Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study
Authors: Sabrina Welland, Ann-Kristin Zöller, Ilektra A. Mavroeidi, Aurelie Tomczak, Christian Müller, Dong Yawen, Danmei Zhang, Felix Keil, Maria Pangerl, Taotao Zhou, Hossein Taghizadeh, Sebastian Lange, Maximilian N. Kinzler, Kataryna Shmanko, Maryam Barsch, Carolin Zimpel, Angela Djanani, Henning Schulze-Bergkamen, Julius Keyl, Florian Lüke, Thomas Wirth, Michael Dill, Thomas Longerich, Sophia Petschnak, Jens U. Marquardt, Michael Quante, Arndt Weinmann, Dirk Walter, Nicole Pfarr, Gerald Prager, Bernhard Doleschal, Maria A. Gonzalez-Carmona, Rainer Günther, Alexander Scheiter, Stefan Böck, Stephan Bartels, Thomas Gruenberger, Marino Venerito, Christoph Springfeld, Stefan Kasper, Anna Saborowski, Arndt Vogel.
Read the full article here.
More posts featuring Arndt Vogel.